Source: International Atomic Energy Agency – IAEA
The IAEA and the Radiological Society of North America (RSNA) have signed a strategic partnership agreement to build professional capacity in radiology across low- and-middle-income countries (LMICs), for bolstered diagnostic and medical imaging capabilities in underserved regions across the world.
The agreement was signed by Najat Mokhtar, IAEA Deputy Director General and Head of the Department of Nuclear Sciences and Applications and Mark G. Watson, RSNA Executive Director earlier this month.
“RSNA is proud to be part of this partnership with the IAEA, and we look forward to working together to raise awareness and address health care disparities in underserved areas,” Watson said. “RSNA is strongly committed to promoting health equity and improving access to care around the world. Through collaborations such as this, we are able to bring high-quality radiology resources and training to the places that need them most.”
RSNA supports patient care through education, research and technological innovation. Its members span the full breadth of radiology subspecialities and represent over 150 countries. By leveraging RSNA’s extensive network and resources, the IAEA seeks to amplify its efforts in promoting equitable access to high quality radiology services in LMICs, notably through its Rays of Hope initiative.
“The IAEA-RSNA collaboration is a commitment to expand our efforts in combatting global healthcare disparities, particularly in cancer care,” said Mokhtar. “Imaging is an integral part of cancer care, but unfortunately there are still countries that do not have access to diagnostic tools and procedures which are integral for the proper diagnosis and staging of cancer in patients — this collaboration will be a step forward towards building these capacities,” she said.
Medical imaging plays a vital role in achieving the best health outcomes for cancer patients — it is an essential tool used to guide all major medical decisions, from diagnosis to disease staging, therapeutic planning and the assessment of therapeutic response.